Gregory M. C. Orleski
Director/Board Member at 10379085 Canada, Inc.
Gregory M. C. Orleski active positions
| Companies | Position | Start | End |
|---|---|---|---|
10379085 Canada, Inc.
 10379085 Canada, Inc. Financial ConglomeratesFinance 10379085 Canada, Inc. is an investment holding Canadian company founded in 2017. The private company is based in Montréal, Canada. | Director/Board Member | - | - |
Career history of Gregory M. C. Orleski
Former positions of Gregory M. C. Orleski
| Companies | Position | Start | End |
|---|---|---|---|
| CRESCITA THERAPEUTICS INC. | Director/Board Member | 2016-08-31 | 2016-11-02 |
| Chief Executive Officer | 2016-08-31 | 2016-11-02 | |
| ABBOTT INDIA LIMITED | Director/Board Member | 2007-09-20 | 2007-09-20 |
Uman Pharma, Inc.
 Uman Pharma, Inc. Pharmaceuticals: GenericHealth Technology Uman Pharma, Inc. develops, manufactures, and markets generic injectable pharmaceutical products. The company was founded in December 20, 2007 and is headquartered in Montreal, Canada. | Director/Board Member | - | - |
INTEGA Skin Sciences, Inc.
 INTEGA Skin Sciences, Inc. Pharmaceuticals: MajorHealth Technology INTEGA Skin Sciences, Inc. is a dermatology company, which offers treatment and care products for skin diseases and their symptoms. The company was founded by Gregory M.C. Orleski in 2015 and is headquartered in Montreal, Canada.^ | Chief Executive Officer | 2014-12-31 | - |
| Founder | 2014-12-31 | - | |
| President | 2014-12-31 | - | |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - | - |
Chlorion Pharma, Inc.
 Chlorion Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Chlorion Pharma, Inc. Develops small molecule leads for the treatment of naturopathic pain and epilepsy. It develops therapeutics for the treatment of neuropathic pain and epilepsy. The company was founded by Jeffrey A. M. Coull, Yves De Koninck and Martin Gagnon in 2004 and is headquartered in Laval, Canada. | Chairman | 2009-10-14 | - |
Labopharm, Inc.
 Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Corporate Officer/Principal | - | - |
Training of Gregory M. C. Orleski
| McGill University | Graduate Degree |
| University of Alberta | Undergraduate Degree |
Statistics
International
| Canada | 9 |
| United States | 2 |
| India | 2 |
Operational
| Director/Board Member | 4 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ABBOTT INDIA LIMITED | Health Technology |
| CRESCITA THERAPEUTICS INC. | Health Technology |
| Private companies | 5 |
|---|---|
Labopharm, Inc.
Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Health Technology |
Uman Pharma, Inc.
Uman Pharma, Inc. Pharmaceuticals: GenericHealth Technology Uman Pharma, Inc. develops, manufactures, and markets generic injectable pharmaceutical products. The company was founded in December 20, 2007 and is headquartered in Montreal, Canada. | Health Technology |
INTEGA Skin Sciences, Inc.
INTEGA Skin Sciences, Inc. Pharmaceuticals: MajorHealth Technology INTEGA Skin Sciences, Inc. is a dermatology company, which offers treatment and care products for skin diseases and their symptoms. The company was founded by Gregory M.C. Orleski in 2015 and is headquartered in Montreal, Canada.^ | Health Technology |
10379085 Canada, Inc.
10379085 Canada, Inc. Financial ConglomeratesFinance 10379085 Canada, Inc. is an investment holding Canadian company founded in 2017. The private company is based in Montréal, Canada. | Finance |
Chlorion Pharma, Inc.
Chlorion Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Chlorion Pharma, Inc. Develops small molecule leads for the treatment of naturopathic pain and epilepsy. It develops therapeutics for the treatment of neuropathic pain and epilepsy. The company was founded by Jeffrey A. M. Coull, Yves De Koninck and Martin Gagnon in 2004 and is headquartered in Laval, Canada. | Commercial Services |
